These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28062628)

  • 21. Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.
    Foo JY; Wan Y; Schulz BL; Kostner K; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
    Clin Chem; 2013 Oct; 59(10):1523-31. PubMed ID: 23820130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.
    Takase H; Dohi Y
    Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.
    Clerico A; Fontana M; Zyw L; Passino C; Emdin M
    Clin Chem; 2007 May; 53(5):813-22. PubMed ID: 17384013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes.
    Fadini GP; Bonora BM; Albiero M; Zaninotto M; Plebani M; Avogaro A
    Cardiovasc Diabetol; 2017 Feb; 16(1):22. PubMed ID: 28183314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head-to-head comparison of 10 natriuretic peptide assays.
    Collin-Chavagnac D; Dehoux M; Schellenberg F; Cauliez B; Maupas-Schwalm F; Lefevre G;
    Clin Chem Lab Med; 2015 Oct; 53(11):1825-37. PubMed ID: 25996187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a BNP1-32 Immunoassay That Does Not Cross-React with proBNP.
    Lewis LK; Raudsepp SD; Yandle TG; Prickett TC; Richards AM
    Clin Chem; 2017 Jun; 63(6):1110-1117. PubMed ID: 28428353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery.
    St Peter JV; Hartley GG; Murakami MM; Apple FS
    Clin Chem; 2006 Apr; 52(4):680-5. PubMed ID: 16497939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure.
    Lewis LK; Raudsepp SD; Prickett TCR; Yandle TG; Doughty RN; Frampton CM; Pemberton CJ; Richards AM
    Clin Chem; 2019 Sep; 65(9):1115-1124. PubMed ID: 31092393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of sample types for N-terminal pro-B-type natriuretic peptide measured on the Siemens Immulite 2500 and Dimension Vista LOCI methods.
    Peake RW; Turner HE; Leaper W; Deans KA; Hannah A; Croal BL
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):494-6. PubMed ID: 22896660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capability of B-type natriuretic peptide (BNP) and amino-terminal proBNP as indicators of cardiac structural disease in asymptomatic patients with systemic arterial hypertension.
    Mueller T; Gegenhuber A; Dieplinger B; Poelz W; Haltmayer M
    Clin Chem; 2005 Dec; 51(12):2245-51. PubMed ID: 16223888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
    Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
    Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for functional heterogeneity of circulating B-type natriuretic peptide.
    Liang F; O'Rear J; Schellenberger U; Tai L; Lasecki M; Schreiner GF; Apple FS; Maisel AS; Pollitt NS; Protter AA
    J Am Coll Cardiol; 2007 Mar; 49(10):1071-8. PubMed ID: 17349887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.
    Miller WL; Hartman KA; Grill DE; Burnett JC; Jaffe AS
    Clin Chem; 2009 Jan; 55(1):78-84. PubMed ID: 19028821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment.
    Nougué H; Michel T; Picard F; Lassus J; Sadoune M; Laribi S; Cohen-Solal A; Logeart D; Launay JM; Vodovar N
    Clin Chem; 2023 Apr; 69(4):350-362. PubMed ID: 36762414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.
    Nakagawa Y; Nishikimi T; Kuwahara K; Yasuno S; Kinoshita H; Kuwabara Y; Nakao K; Minami T; Yamada C; Ueshima K; Ikeda Y; Okamoto H; Horii K; Nagata K; Kangawa K; Minamino N; Nakao K
    PLoS One; 2014; 9(3):e92314. PubMed ID: 24667631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New issues on measurement of B-type natriuretic peptides.
    Clerico A; Zaninotto M; Passino C; Plebani M
    Clin Chem Lab Med; 2017 Nov; 56(1):32-39. PubMed ID: 28809748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.